10.1038leu.2017.36.ann

T1 Protein 494 498 p210
T2 Gene 14 22 isoforms
T3 Condition 166 194 chronic myelogenous leukemia
T4 Protein 753 757 p210
T5 Condition 235 270 B-cell acute lymphoblastic leukemia
T6 Condition 987 1010 leukemic transformation
T7 Protein 48 56 tyrosine
T8 Gene 786 825 Stat5 transcription factor and the Erk1
T9 Biomarker 649 666 clathrin-mediated
T10 Protein 551 559 tyrosine
T11 Protein 503 507 p190
T12 Protein 74 78 p190
T13 Intervention 116 126 chromosome
T14 Protein 1060 1077 kinase inhibitors
T15 Protein 40 47 Bcr–Abl
T16 Protein 204 208 p190
T17 Protein 30 63 oncogenic Bcr–Abl tyrosine kinase
T18 Protein 287 294 protein
T19 Gene 867 877 Lyn kinase
T20 Protein 731 735 Sts1
T21 Protein 402 406 p210
T22 Protein 535 546 interactome
T23 Protein 65 69 p210
T24 Protein 614 633 AP2 adaptor complex
T25 Protein 894 898 p190
T26 Protein 411 415 p190
T27 Protein 142 146 p210
T28 Protein 709 713 p190
T29 Protein 954 961 Bcr–Abl
T30 Protein 853 857 p210
T31 Gene 826 835 2 kinases
R1 Relation Arg1:T21 Arg2:T26